United Capital Corp. (NYSE Amex: AFP) announced today that its common stock will cease trading on the NYSE Amex and transition to the OTC Pink tier, operated by OTC Markets Group, effective with the opening of business on Thursday, July 28, 2011. The Company’s new symbol for trading on the OTC Pink tier will be UCAP. As previously announced on June 17, 2011, the Board of Directors of United Capital approved the voluntary delisting of its common stock from the NYSE Amex and the deregistration of its securities with the Securities and Exchange Commission. As its common stock is expected to be quoted on OTC Pink tier, the Company plans to make future disclosures available through the OTC Markets Group on their website at www.otcmarkets.com. Certain statements in this press release and other statements made by the Company or its representatives that are not strictly historical facts are “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995 that should be considered as subject to the many risks and uncertainties that exist in the Company's operations and business environment. The forward-looking statements are based on current expectations and involve a number of known and unknown risks and uncertainties that could cause the actual results, performance and/or achievements of the Company to differ materially from any future results, performance or achievements, expressed or implied, by the forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, and that in light of the significant uncertainties inherent in forward-looking statements, the inclusion of such statements should not be regarded as a representation by the Company or any other person that the objectives or plans of the Company will be achieved. The Company also assumes no obligation to publicly update or revise its forward-looking statements or to advise of changes in the assumptions and factors on which they are based. See our 2010 Annual Report on Form 10-K for a discussion of risk factors that could impact our future financial performance and/or cause actual results to differ significantly from those expressed or implied by such statements.